Health News Archive - May 09, 2011
PEABODY, Mass., May 9, 2011 /PRNewswire/ -- PHC, Inc., d/b/a Pioneer Behavioral Health (NYSE Amex: PHC), a leading provider of inpatient and outpatient behavioral health services, today announced that effective March 1, 2011, it had instituted a 28% rate increase with a major Las Vegas customer through its Harmony Healthcare unit, which will add approximately $2.0 million annually to Pioneer's revenues.
CHICAGO, May 9, 2011 /PRNewswire/ -- ImmusanT, Inc., a biotechnology company developing an immunotherapeutic vaccine, companion diagnostic and monitoring tool for celiac disease, reported positive results from a Phase 1 study evaluating the safety, tolerability and bioactivity of Nexvax2Â® in patients with celiac disease.
BALTIMORE and LIEGE, Belgium, May 9, 2011 /PRNewswire/ -- BD Diagnostics, a segment of global medical technology company BD (Becton, Dickinson and Company) (NYSE: BDX), and Diagenode SA, an international biotech company based in Belgium, announced today an agreement to co-develop seven initial molecular diagnostic assays on the BD MAX(TM) System for pathogens associated with respiratory, enteric and central nervous system diseases.
FLORHAM PARK, N.J., May 9, 2011 /PRNewswire/ -- Shionogi Inc., the U.S.-based group company of Shionogi & Co., Ltd., today announced the publication in Pediatrics of data demonstrating the efficacy of non-stimulant KAPVAY(TM) (clonidine hydrochloride) extended-release tablets when combined with stimulant medications for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in children and adolescents (6-17 years).
NEW YORK, May 9, 2011 /PRNewswire/ -- Birds Nest Foundation (Birds Nest), a 501(c)3 organization founded to provide services to other non-profit organizations, today announced it has donated edible, academic gardens to 100 public schools throughout the New York City boroughs.
MADISON, N.J., May 9, 2011 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced today that Spark Acquisition Corporation, its wholly owned subsidiary ("Spark"), has extended the cash tender offer for all outstanding shares of common stock of Celera Corporation (NASDAQ: CRA).
ROCKVILLE, Md., May 9, 2011 /PRNewswire/ -- Novavax, Inc.
CHICAGO, May 9, 2011 /PRNewswire/ -- New study findings showed that treatment with STELARAÂ® (ustekinumab) induced and maintained clinical response in patients with moderate to severe Crohn's disease who had previously failed or were intolerant to at least one tumor necrosis factor (TNF) antagonist.
MILPITAS, Calif., May 9, 2011 /PRNewswire/ -- AmbiCom Holdings, Inc.
SANTA CLARA, Calif., May 9, 2011 /PRNewswire/ -- Cell Biosciences, Inc. today announced the issuance of three key patents by the United States Patent and Trademark Office, Patent Nos.
- The deadly nightshade, Atropa Belladonna, which possesses stupefying or poisonous properties.
- A sleeping-potion; a soporific.
- To mutter deliriously.